| Literature DB >> 1697710 |
A Marczyńska1, J Kulpa, J Leńko, A Bugajski, E Wójcik.
Abstract
CA-50 antigen is considered to be a generalized carcinoma-associated antigen. CA-50 serum levels were measured by solid phase radioimmunoassay using a specific monoclonal antibody. Sera of 49 patients with prostatic cancer of different clinical stages, 43 patients suffering from BPH, and 28 healthy males were tested. Positive test results were observed in 57.1% of patients with prostate cancer values ranging from 42.9% in stage A to 66.7% in stage D. Increased CA-50 levels were found in 11.6% of patients with BPH.Entities:
Mesh：
Substances：
Year: 1990 PMID： 1697710 DOI： 10.1007/bf00295845
Source DB: PubMed Journal: Urol Res ISSN： 0300-5623